Ludwig Burger

Bayer lifted by new plan to tackle glyphosate lawsuits, Elliott approval

27 Jun 2019

BERLIN Bayer shares jumped on Thursday after it revealed plans aimed at resolving multi-billion dollar lawsuits linked to glyphosate, a move welcomed by activist shareholder Elliott, which has taken a sizeable stake in the chemicals company.

BASF legt mit Sparprogramm los und streicht 6000 Stellen

27 Jun 2019

Frankfurt BASF-Chef Martin Brudermüller macht Ernst: Im Herbst kündigte er ein Sparprogramm an, nun kommt der Abbau von weltweit 6000 Stellen.

Germany's BASF to cut 6,000 jobs, mainly in administration

27 Jun 2019

BERLIN BASF will cut 6,000 jobs worldwide, mainly involved in its central administration, in a move it said will achieve annual savings of 300 million euros ($341 million) from 2021 and give more power to customer-facing executives.

GSK kicks off sale of $1.2 billion consumer health drugs: sources

19 Jun 2019

LONDON GlaxoSmithKline (GSK) has kicked off the sale of some consumer health brands as it seeks to raise about 1 billion pounds ($1.26 billion) before pressing ahead with a spinoff of its consumer healthcare business, sources told Reuters.

GSK pharma head flags need for speed in high-pressure drug market

17 Jun 2019

LONDON Doing things one at a time in drug development is not a luxury that GlaxoSmithKline can afford any longer, the head of pharmaceuticals at Britain's largest drugmaker told Reuters.

Bayer lotet Glyphosat-Alternativen aus - verspricht Besserung

14 Jun 2019

Frankfurt Nach Manager-Schelte, Kursverfall und einer Klagewelle in den USA versucht Bayer, wieder in die Offensive zu kommen:

Bayer to invest $5.6 billion in weedkiller research to help reputation

14 Jun 2019

FRANKFURT Germany's Bayer sought to repair its reputation on Friday after damage caused by U.S. litigation over claims its glyphosate pesticide causes cancer, saying it would invest 5 billion euros ($5.6 billion) in weedkiller research.

GSK signs up gene-editing pioneers in drug discovery alliance

13 Jun 2019

British drugmaker GSK said it has struck a research deal with the early pioneers of a prominent gene-editing technology at the University of California, in a boost to its prospects for developing new drugs.

Fresenius says tighter EU rules could trigger antibiotic shortage

05 Jun 2019

FRANKFURT German drugmaker Fresenius warned that stricter production norms being considered by Europe's drug regulator could compound shortages of a life-saving antibiotic that is used by about 25 million patients globally each year.

World News